Purdue, Lilly establish new medical-focused research center
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
Purdue University and Indianapolis-based Eli Lilly and Co. on Monday announced a new effort to bolster research and development of new technologies and medicines.
The Eli Lilly and Company and Purdue University Research Alliance Center, or LPRC, is part of an existing partnership between the two entities that was expanded in 2023.
Purdue said in a news release that the LPRC will serve as an “essential hub for collaborative exploration of new technologies that enhance every phase of pharmaceutical research, from discovery to delivery.”
The collaboration involves more than 50 researchers and 65 graduate students that will engage in key research to build on previous accomplishments that resulted in over 130 publications, eight patents and one copyright.
“Purdue and Lilly researchers have long demonstrated the strength that’s gained by working together,” Karen Plaut, Purdue’s executive vice president for research, said in the release. “Through this center, we will continue to make better science and scientists for the future.”
Currently, LPRC researchers from both entities are focusing on genetic medicine, intrathecal delivery and nanoparticle drug delivery. Purdue said the research being done will help Lilly investigate the development of medicines to improve the pace of getting those treatments to patients.
Purdue noted that the LPRC will also support the university’s recently announced One Health initiative, which received an endorsement by the Purdue board of trustees in June. The initiative is designed to advance the university’s strengths in human, animal, plant, environmental health, as well as partnership opportunities in West Lafayette, Indianapolis and Lebanon.